日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

O-GlcNAcylation regulates the DNA damage repair function of MND1 in breast cancer

O-GlcNAc糖基化调控MND1在乳腺癌中的DNA损伤修复功能

Zhai, Zhen; Wu, Jinpeng; Wei, Yumeng; Song, Ping; Wang, Meng; Lin, Shuai; Ma, Xiaobin; Lu, Yurong; Yang, Pengbo; Tan, Zengqi; Guan, Feng; Li, Xiang; Kang, Huafeng

Nasal negative pressure oscillatory therapy versus oscillatory positive expiratory pressure for airway clearance in patients with acute exacerbations of bronchiectasis (NNPO-BE): a multicentre, randomised, crossover non-inferiority trial protocol

鼻负压振荡疗法与振荡呼气正压疗法治疗急性支气管扩张症患者气道清除效果的比较(NNPO-BE):一项多中心、随机、交叉非劣效性试验方案

Wang, Siyuan; Zhou, Zhaobin; Ma, Xiaobin; Yang, Yang; Lei, Jieping; Shiwei, Qumu; Gao, Beiyao; Wang, Peijian; Le, Man; Jiang, Shan; Yang, Ting

Ischemic Area-Targeting and Self-Monitoring Nanoprobes Ameliorate Myocardial Ischemia/Reperfusion Injury by Scavenging ROS and Counteracting Cardiac Inflammation.

缺血区域靶向和自监测纳米探针通过清除 ROS 和对抗心脏炎症来改善心肌缺血/再灌注损伤

Ma Xiaobin, Fan Zhijin, Peng Jingyan, Nie Liming

Bispecific Antibody Targeting VEGF/TGF-β Synergizes with Local Radiotherapy: Turning Tumors from Cold to Inflamed and Amplifying Abscopal Effects.

靶向 VEGF/TGF-β 的双特异性抗体与局部放射疗法协同作用:将肿瘤从冷肿瘤转变为炎症肿瘤,并增强远隔效应

Lyu Lijuan, Yi Ming, Chen Ji, Zhang Jing, Ma Xiaobin, Zhang Xiaojun, Zeng Liang, Xue Yan, Wen Haimei, Deng Yujiao, Zhou Pengfei, Wu Kongming, Kang Huafeng, Dai Zhijun

Bisecting GlcNAc enhances CD8(+) T cell-mediated killing of breast cancer by suppressing PD-L1 expression and its binding to PD-1.

二分 GlcNAc 通过抑制 PD-L1 表达及其与 PD-1 的结合,增强 CD8(+) T 细胞介导的乳腺癌杀伤作用

Ren Xueting, Wu Jinpeng, Li Jing, Zhai Zhen, Li Xiang, Guan Feng, Wang Meng, Ma Xiaobin, Tan Zengqi, Kang Huafeng, Lin Shuai

Smoking cessation improves health status of patients with chronic diseases: evidence from a longitudinal study of older adults in China

戒烟改善慢性病患者的健康状况:来自中国老年人纵向研究的证据

Zhu, Haoyu; Xu, Peng; Wei, Yumeng; Zhao, Chuchen; Zhao, Danni; Li, Yaxin; Ma, Xiaobin; Wang, Meng; Kang, Huafeng

Accurate HER2 determination in breast cancer: a prominent COF-immobilized enzyme-enhanced electrochemical aptasensor employing 4-acetamidophenol as an efficient mediator

乳腺癌中 HER2 的准确测定:采用 4-乙酰氨基苯酚作为有效介质的突出的 COF 固定化酶增强电化学适体传感器

Yue Zhang, Shuyi Chen, Jie Ma, Xiaobin Zhou, Xinchen Sun, Chenglin Zhou

Favorable outcome of neoadjuvant endocrine treatment than surgery-first in female HR-positive/HER2-negative breast cancer patients-A NCDB analysis (2010-2016)

对于 HR 阳性/HER2 阴性乳腺癌女性患者,新辅助内分泌治疗比先手术治疗效果更佳——NCDB 分析(2010-2016 年)

Xu, Peng; Luo, Wen; Hu, Jingjing; Ma, Xiaobin; Hao, Qian; Hui, Wentao; Zhou, Zhangjian; Lin, Shuai; Wang, Meng; Wu, Hao; Dai, Zhijun; Kang, Huafeng

Impact of response to neoadjuvant chemotherapy on surgical modality in patients with T1-2N0-1M0 triple-negative breast cancer

新辅助化疗反应对T1-2N0-1M0三阴性乳腺癌患者手术方式的影响

Chang, Lidan; Liu, Dandan; Hao, Qian; Ren, Xueting; Liu, Peinan; Liu, Xingyu; Wei, Yumeng; Lin, Shuai; Ma, Xiaobin; Wu, Hao; Kang, Huafeng; Wang, Meng

PIK3CA mutation-driven immune signature as a prognostic marker for evaluating the tumor immune microenvironment and therapeutic response in breast cancer

PIK3CA突变驱动的免疫特征可作为评估乳腺癌肿瘤免疫微环境和治疗反应的预后标志物

Ren, Xueting; Cui, Hanxiao; Dai, Luyao; Chang, Lidan; Liu, Dandan; Yan, Wenyu; Zhao, Xuyan; Kang, Huafeng; Ma, Xiaobin